May 19, 2022 05:23 AM

CHINA

Shanghai Speeds Up Customs Clearance of Covid Vaccines and Materials

By Bao Zhiming and Denise Jia

China National Biotec Group’s mRNA Covid vaccine displayed at the China International Fair for Trade in Services in September 2021.

China National Biotec Group’s mRNA Covid vaccine displayed at the China International Fair for Trade in Services in September 2021.

Shanghai will open a “green channel” to speed up health quarantine approval procedures for Covid-19 vaccines, treatment drugs and other anti-epidemic materials, a customs official said Wednesday.

Shanghai is the center of China’s biomedical research and development industry, and most of the research and development of advanced mRNA vaccines are taking place in the city, which has been battling a surge of Covid cases since March.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: China Celebrates Golden Week

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: Why Singapore Sovereign Fund Sues Chinese EV-Maker Nio

00:00

00:00/00:00

MOST POPULAR

1: Cover Story: U.S. and Chinese Chipmakers Tread Different Paths in AI Gold Rush

2: Shenzhen’s Secondhand Home Sales Briefly Rebound in September After Easing of Purchase Restrictions

3: Xiaomi, EV Rivals Offer Tax Subsidies Ahead of China’s 2026 Incentive Cut

4: China’s MetaX Wins IPO Nod as AI Chipmakers Race to Go Public

5: In Depth: Chip Foundries Kick Off State-Backed Consolidation Drive

SPONSORED

OR